(Do not) ENACT!!!!
An episode of the GU Cast | Urology Podcast podcast, hosted by Professor Declan Murphy & Dr Renu Eapen, titled "(Do not) ENACT!!!!" was published on June 25, 2022 and runs 46 minutes.
June 25, 2022 ·46m · GU Cast | Urology Podcast
Summary
Wow did this paper cause a fuss this week!! The ENACT trial was published online in JAMA Oncology last weekend and provoked a huge outcry on social media. Many people were genuinely shocked at the study design, the conclusions, even the title of the study. We've linked to the paper below, but in summary, this prospective multi centre study enrolled patients with with low-risk or favourable intermediate-risk prostate cancer, entirely suitable for active surveillance (ie no treatment/no ...
Episode Description
Wow did this paper cause a fuss this week!! The ENACT trial was published online in JAMA Oncology last weekend and provoked a huge outcry on social media. Many people were genuinely shocked at the study design, the conclusions, even the title of the study.
We've linked to the paper below, but in summary, this prospective multi centre study enrolled patients with with low-risk or favourable intermediate-risk prostate cancer, entirely suitable for active surveillance (ie no treatment/no side-effects), and randomised half of them to receive enzalutamide. Yes enzulautmide, a super powerful AR pathway inhibitor that works very well in men with advanced prostate cancer. But with plenty of side-effects.
So we decided to invite study co-author, active surveillance advocate and friend of teh podcast, Dr Matt Cooperberg, to come on and help us understand the rationale. We also welcomed Dr Keith Kowalczyk, Georgetown Medical Centre, Washington DC, to help us figure it out.
What do you think? Comments welcome on our Youtube channel
Links:
ENACT paper
Similar Episodes
Aug 20, 2020 ·7m
Apr 7, 2020 ·7m
Apr 3, 2020 ·7m
Oct 29, 2019 ·8m
Jul 20, 2018 ·24m
Jul 20, 2018 ·12m